What the studies show
Replaces the missing hormone; the standard treatment since the 1970s. Older trials, not modern RCTs, but the effect is unambiguous.
Several well-run randomised trials in people, pointing the same way. You can plan around this. It still says nothing about whether the effect is worth the side effects for you.
- 1Hahn D, et al. Desmopressin for nocturnal enuresis in children.Cochrane Database Syst Rev, 2025
In context
Desmopressin is a synthetic analogue of the antidiuretic hormone vasopressin that concentrates urine without raising blood pressure. It is approved for diabetes insipidus, bedwetting, nocturia and some bleeding disorders. A Cochrane review of 14 trials found it reduces night-time voids by a little under one per night in men. Its serious risk is hyponatraemia — low blood sodium — in about 7.6% of older adults, which is why sodium is monitored. It is on WADA's list as a masking agent.
Desmopressin is approved (rx). Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is Desmopressin proven to help with central diabetes insipidus?
What studies are behind the grade?
Is Desmopressin approved for this?
Other outcomes for Desmopressin
- ANocturia (night-time voids)Cochrane review, 14 RCTs (n=2,966 men)
- AHyponatraemia (older adults)adverseMeta-analysis, 7 studies
- ANocturnal enuresis in childrenCochrane review (2025 update)
Written and maintained by LYO Research — how pages are written and checked. Reviewed 23 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →